Does RIBAVIRIN Cause Hepatocellular carcinoma? 1,046 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,046 reports of Hepatocellular carcinoma have been filed in association with RIBAVIRIN (Ribavirin). This represents 2.4% of all adverse event reports for RIBAVIRIN.
1,046
Reports of Hepatocellular carcinoma with RIBAVIRIN
2.4%
of all RIBAVIRIN reports
151
Deaths
263
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From RIBAVIRIN?
Of the 1,046 reports, 151 (14.4%) resulted in death, 263 (25.1%) required hospitalization, and 78 (7.5%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBAVIRIN. However, 1,046 reports have been filed with the FAERS database.
What Other Side Effects Does RIBAVIRIN Cause?
Fatigue (5,565)
Anaemia (5,130)
Nausea (4,434)
Headache (3,497)
Rash (2,686)
Insomnia (2,653)
Pruritus (2,490)
Pyrexia (2,487)
Drug ineffective (2,364)
Vomiting (2,280)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
SOFOSBUVIR\VELPATASVIR (161)
Which RIBAVIRIN Alternatives Have Lower Hepatocellular carcinoma Risk?
RIBAVIRIN vs RIBOCICLIB
RIBAVIRIN vs RIBOFLAVIN
RIBAVIRIN vs RIBOFLAVIN 5'-PHOSPHATE
RIBAVIRIN vs RIBOFLAVIN 5^-PHOSPHATE
RIBAVIRIN vs RIFABUTIN